Member Info for SneakySimon

We make, per test, 3x as much from the Mologic antigen test - I don't especially want the Anitbody test to take up too much capacity.

Antibody testing will be longer term - initially just a lot of analysis and then wider use so hopefully when antigen demand drops or our capacity increases further, the antibody testing will kick in.....

Only dropped a bit - since we were at one point we were 7% down and all that has happened is a tweet with info which is not new news, I am pretty happy at a flat day.....

Look out for the late prints, suspect there will be a few!

"To ring fence your holdings!"

Eh?

I think it was carefully worded and mentioning the Mologic test I think was significant - since it will be a Visitect branded test once transferred (obviously a Mologic designed test) - intrigued what is happening is this area
- it was to link to Mologic as they are big name and been linked to govt tenders
- we may not brand it as Visitect short term but instead supply to Mologic and onto govt
- we may never rebrand it visitect and remain supplying to Mologic

I like that they called it the Mologic antige test rather than the antigen test or visitect test - calling it Mologic beautifully links it to Mologic who are smashing it.

Anyway wonder if we would supply to Mologic as part of the contract they have potentially have with the government?

good start - now more of this - not everyday, just something to keep the connection alive and prove that ODX is still working!

production at least 6 months from now - shows that Covid testing will be around for sometime....

imagine it was 2m per day!

I know Calderkate, I was being sarcastic at the suggestion that missing covid from the RNS implied something sinister!

Chriszzer, I suspect that Colin has decided to not to Covid tests anymore - he never got so many queries pre covid - the last straw being the dog walker talking pictures. Binned it mate. Sell quick before all other investors catch on - good spot mate

"""Wonder why they did not mention Covid tests in the RNS, perfect opportunity to hint at things to come

"Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing,""""

"Are being flushed out."

This gets said almost everyday............

Concur on the NDA with the UKRTC test - we don't own it, but we can share a lot of other info if they wanted to:
- recruitment performance 'hey, we just recruited our 150th employee for all that manufacturing we are going to have to do'
- manufacturing increase 'hey, we just reached 500k daily production for all that manufacturing we are going to have to do'
- tech transfer ' going well, here is a video, we expect to finish by mid January'

Blah blah blah - just anything to get a bit of news out there and stop this daily drop.

7 of the 9 trading days since Xmas eve have been drops - most over 4%..........

My issue is that as CEO, he should be doing more to support the SP / shareholders.

The communication hasn't been great so far - tech transfer started was dropped hidden deep inside a 26 min presentation and had to be clarified by Walbrook a few days later.

We have had a decent rise for example on the 24th December from the Mologic CE - yet nothing from then and again, we drift downwards with no news - we started that day at 51.50, closed at 66p - a rise of 28% - we have now all but given that away yet we are in a better place - why? Nothing to follow it up, to keep the SP sustained.

Now imagine we get some decent RNS's - a 20% rise from here will take us to just over 60p - if though they had actually bothered to communicate - confirm the manufacturing uplift, the status of the tech transfer etc then we would be looking at a closing SP of 70's, maybe 80's. What I am saying is, the SP is a reflection of the poor PR. I don't want hand holding, but I do want to be able to make informed decisions on my large investment. To see the SP drop 20% or so because of a lack of communication does not instill a lot of confidence in the CEO's attitude to shareholders and thus, the long term SP price.

thats what they found with the Innova etc - when lab based 76% but obviously that drops when put in the hands of people - I think Innova came out @50-55%,

Yet to see the Mologic results in the field but since they are starting at almost 20% more sensitivity, you would hope it would be at least 20% higher than Innova?

South Africa he made some claim that South Africa have a 6 month period of tenders or some other BS...........

hasten to add, not saying it does not work, only that it maybe is not quite as good as they claim ;-)

I found this pretty interesting about the Pfizer detailed results - I had a scan through the data and there are some interesting inconsistencies:

- number of 'suspected Covid-19' in both groups (1594 occurred in the vaccine group vs. 1816 in the placebo group)
- 371 people excluded from the effiacy - 311 removed form the vaccine group but no details on why
- despite meant to be a trial with only people without covid antibodies, 3% already had the antibodies

https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/

"Ticking up nicely after a not so good start to the year!

Fully expecting news flow next week on the following:
1) Tech Transfer
2) Capacity Update (as looks like we can’t update on sales data on Covid products)

Bonus news would be:
1) Update on MHRA
2) Non Covid sales update"

Totally agree, though not expecting MHRA sign off for a little while - the news will be all about the Antigen LFT short term for ODX.

maybe he is refering to the Azn vaccine? I don't think that has yet been confirmed unless I have missed it?

"Transport Secretary Grant Shapps warns Covid vaccines might not work on South African strain.... just hours after Pfizer study finds key mutation in super-infectious variant has NO effect on their jab"

Topcat

"So do you agree we should buy Chinese test not the British that would keep people in a job and help put money into the treasury?"

Tell me in 2020 where UKGOV could have bought millions of LFT antigen tests from?